Landmark study launches to map the journey of a rare, incurable disease
NCT ID NCT04265144
Summary
This study aims to understand the natural progression of systemic sclerosis (scleroderma), a rare and serious autoimmune disease with no cure. Researchers will follow 500 patients for five years, collecting detailed health information and blood samples. The goal is to build a clearer picture of how the disease develops and what complications arise, which is essential for future research into treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Bordeaux - service de rhumatologie
RECRUITINGBordeaux, France
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.